Pancreatic Cancer Research

ResearcherDuke UniversityActive in the last 2 years

Desiree E. Morgan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5198-3639; OpenAlex author ID A5000571508. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 10

  1. Quantitative dynamic contrast-enhanced magnetic resonance imaging for early assessment of treatment response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00330-026-12810-2↗
  2. PET/MRI for evaluation of patients with pancreatic cancer. Co-author DOI 10.1007/s00261-023-03943-9↗
  3. Exploratory analysis of mesenteric-portal axis CT radiomic features for survival prediction of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00330-023-09532-0↗
  4. CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study. Co-author DOI 10.1148/radiol.2021210699↗
  5. Pancreatic Ductal Adenocarcinoma: Interface Enhancement Gradient Measured on Dual-Energy CT Images Improves Prognostic Evaluation. Last author DOI 10.1148/rycan.2020190074↗
  6. Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Poi… First author DOI 10.1097/rli.0000000000000505↗
  7. A Case of Pancreatic Cancer: Abdominal Anatomy Team-Based Learning Module for Medical Students. First author DOI 10.15766/mep_2374-8265.10700↗
  8. Imaging preoperatively for pancreatic adenocarcinoma. First author DOI 10.3978/j.issn.2078-6891.2015.024↗
  9. Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging. Last author DOI 10.1007/s00261-014-0107-z↗
  10. Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast. Last author DOI 10.1016/j.crad.2012.06.108↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harrison Kim · 2 shared papers, 2019–2026 · strength 0.34
  2. John Bart Rose · 2 shared papers, 2019–2026 · strength 0.34
  3. Peijie Lyu · 2 shared papers, 2021–2023 · strength 0.28
  4. Francesca Rigiroli · 2 shared papers, 2021–2023 · strength 0.28
  5. Niharika B. Mettu · 2 shared papers, 2021–2023 · strength 0.28
  6. Daniele Marin · 2 shared papers, 2021–2023 · strength 0.28
  7. Martin D. Holland · 1 shared paper, 2026 · strength 0.24
  8. Moh'd M. Khushman · 1 shared paper, 2026 · strength 0.24
  9. Midhun Malla · 1 shared paper, 2026 · strength 0.24
  10. Dana Backlund Cardin · 1 shared paper, 2026 · strength 0.24
  11. Mehmet Akce · 1 shared paper, 2026 · strength 0.24
  12. Sushanth Reddy · 1 shared paper, 2026 · strength 0.24
  13. Bassel F. El‐Rayes · 1 shared paper, 2026 · strength 0.24
  14. Samuel Joseph Galgano · 1 shared paper, 2023 · strength 0.22
  15. Zoey N. Duncan · 1 shared paper, 2023 · strength 0.22
  16. William S. Brooks · 1 shared paper, 2018 · strength 0.14
  17. Rachel Zimmerman Bass · 1 shared paper, 2018 · strength 0.14
  18. Ahmed M. Amer · 1 shared paper, 2020 · strength 0.13
  19. Sabino Zani · 1 shared paper, 2021 · strength 0.11
  20. Jason A. Pietryga · 1 shared paper, 2015 · strength 0.11
  21. Ravi Kumar Paluri · 1 shared paper, 2019 · strength 0.10
  22. Bhavik Natvar Patel · 1 shared paper, 2013 · strength 0.05
  23. John D. Christein · 1 shared paper, 2014 · strength 0.04
  24. Martin J. Heslin · 1 shared paper, 2014 · strength 0.04
  25. Hyunki Kim · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.